Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Pour decisions: Craft beverage enthusiasts add Sunday tasting event to KC’s pregame cart
Kansas City’s roster of craft beverages — from rookies to veteran players on the scene — come to the field in a wide range of uniforms, said Jason Burton, noting there’s no better time to checkout the lineup with thirsty friends than as the Chiefs return to Arrowhead Stadium this weekend. The play: showcase Kansas…
Back to the people: Social venture firm connects WyCo entrepreneurs with a human-centered toolkit
Editor’s note: The following story is presented through a paid partnership with Network Kansas. [divide] An initiative built on collaboration with business boosters already embedded in urban communities is deepening Network Kansas’ impact, said Erik Pedersen, sharing how the strategy helps more readily connect entrepreneurs to available resources like loans and technical assistance. In Wyandotte…
Great Jobs KC aims to impact 50,000 Kansas City scholars within a decade — one life at a time
Editor’s note: The following story was written and first published by the Economic Development Corporation of Kansas City, Missouri (EDCKC). Click here to read the original story. [divide] Natalie Lewis is no stranger to complex work. As chief operating officer of Great Jobs KC, she oversees programs that connect thousands of Kansas Citians with scholarships, tuition-free job…
Black Feast Week returns to feed restaurants new diners, combat hunger in Kansas City
Opening Black Feast Week — designed to promote Black-owned restaurants, chefs, and culinary creativity — by feeding 150 single Black mothers for free was an intentional act of community care, said Joshua “JT” Taylor. “We’ve always tried to prioritize helping people who are most marginalized,” said Taylor, senior content producer and chief administrative officer at…